Perceptive Advisors LLC Lyra Therapeutics, Inc. Transaction History
Perceptive Advisors LLC
- $3.46 Billion
- Q2 2024
A detailed history of Perceptive Advisors LLC transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 12,757,562 shares of LYRA stock, worth $3.57 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
12,757,562
Previous 12,757,562
-0.0%
Holding current value
$3.57 Million
Previous $3.57 Million
-0.0%
% of portfolio
0.1%
Previous 0.1%
Shares
5 transactions
Others Institutions Holding LYRA
# of Institutions
53Shares Held
31.6MCall Options Held
316KPut Options Held
600-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.77MShares$1.34 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.83MShares$792,3930.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA2.78MShares$778,4730.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.73MShares$484,6560.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.06MShares$295,9120.12% of portfolio
About Lyra Therapeutics, Inc.
- Ticker LYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,826,400
- Market Cap $8.91M
- Description
- Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...